Changeflow GovPing Healthcare & Life Sciences High-Throughput Combinatorial Screening System ...
Priority review Rule Added Final

High-Throughput Combinatorial Screening System for Optimized Cas9 Variants

Favicon for changeflow.com USPTO Patent Applications - Biotech (C12N)
Published
Detected
Email

Summary

US20260109973A1 is a published USPTO patent application filed on August 21, 2025, covering a high-throughput combinatorial genetic modification system and optimized SpCas9 enzyme variants produced by that system. The application names Alan Siu Lun Wong and Gigi Ching Gee Choi as inventors and was published on April 23, 2026. As a published application, the invention enters the public record, establishing a priority date and initiating the examination process toward grant.

“Also provided are optimized SpCas9 enzyme variants produced by this system.”

USPTO , verbatim from source
Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Applications - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 246 changes logged to date.

What changed

USPTO published patent application US20260109973A1 covering a high-throughput combinatorial genetic modification system and optimized SpCas9 enzyme variants produced by that system. The application, filed August 21, 2025 under Application No. 19305828, names Alan Siu Lun Wong and Gigi Ching Gee Choi as inventors and was published on April 23, 2026. The published CPC classifications indicate the invention spans C12N gene technology domains including C12N 9/22 (nucleic acid enzymes, specifically Cas9).

Biotechnology companies and academic institutions engaged in CRISPR-based gene editing research and development should evaluate potential freedom-to-operate implications arising from this published application. The patent, once granted, would confer exclusive rights to the combinatorial screening system and optimized Cas9 variants, which could affect licensing negotiations, R&D planning, and competitive positioning in the gene-editing space.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

HIGH-THROUGHPUT COMBINATORIAL GENETIC MODIFICATION SYSTEM AND OPTIMIZED CAS9 ENZYME VARIANTS

Application US20260109973A1 Kind: A1 Apr 23, 2026

Inventors

Alan Siu Lun Wong, Gigi Ching Gee Choi

Abstract

The present invention provides to an improved high-throughput system and method for generated and screening of genetic variants by combinatorial modifications. Also provided are optimized SpCas9 enzyme variants produced by this system.

CPC Classifications

C12N 15/1082 C12N 9/22 C12N 15/1065 C12N 15/11 C12N 15/111 C12N 2310/20 C12N 2800/80

Filing Date

2025-08-21

Application No.

19305828

View original document →

Get daily alerts for USPTO Patent Applications - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
August 21st, 2025
Instrument
Rule
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Biotechnology companies
Industry sector
3254.1 Biotechnology
Activity scope
Patent applications IP licensing Gene editing research
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
3254.1 - Biotechnology Healthcare

Get alerts for this source

We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!